charles river laboratories vs amgen

Stage: Adopting

Key opportunity: AI can accelerate drug discovery and safety assessment by predicting compound toxicity, optimizing study designs, and analyzing complex multi-omic datasets, reducing time-to-clinic for clients.

Stage: Mature

Key opportunity: AI can dramatically accelerate drug discovery and clinical trial design by predicting protein structures, identifying novel therapeutic targets, and optimizing patient recruitment, potentially cutting years and billions from R&D timelines.